Evaluation of Effect and Safety of 'RELUMINO-S'
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0006460
- Lead Sponsor
- Chung-Ang Univerisity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
1.Patients who are 19 years old or older
2.Patients with low vision who are thought not to be able to correct with glasses, contact lenses and surgery
3.Patients with best-corrected visual acuity between 0.48 LogMAR and 1.3 LogMAR in the better eye
4.Vision has been stable for at least for 3 months before the screening
1.Patients who experienced intravitreal injection (ex. Anti-VEGF) or laser therapy within 6 months before the first screening
2.Patients who have disabilities other than low vision
3.Patients with orbital malformation or dermatological disease, unable to wear device
4.Alcohol abuse, drug abuse, mental illness, or significant systemic disease
5.Illiteracy who cannot read Korean
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method